Neurotransmitter transporters as molecular targets for addictive drugs

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 87-96

  Amara, Susan G ^a   Sonders, Mark S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHETAMINE DERIVATIVE; CARRIER PROTEIN; CHLORIDE ION; COCAINE; DOPAMINE; GLUTAMIC ACID; MONOAMINE; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT; SODIUM ION;

AMINO ACID SEQUENCE; BRAIN STEM; CHANNEL GATING; CHLORIDE CURRENT; CORPUS STRIATUM; DRUG DEPENDENCE; HUMAN; HYDROPHOBICITY; LOCOMOTION; MULTIGENE FAMILY; MUTAGENESIS; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PSYCHOMOTOR ACTIVITY; REVIEW; SODIUM CURRENT; STRUCTURE ACTIVITY RELATION; SYNAPSE;

EID: 0032104581     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00068-4     Document Type: Article

References (76)

1. Amara, S.G., Arriza, J.L., 1993. Neurotransmitter transporters: three distinct gene families. Curr. Opin. Neurobiol. 3, 337-344.
2. Amara, S.G., Kuhar, M.J., 1993. Neurotransmitter transporters: recent progress. Ann. Rev. Neurosci. 16, 73-93.
3. Attwell, D., Mobbs, P., 1994. Neurotransmitter transporters. Curr. Opin. Neurobiol. 4, 353-359.
4. Barker, E.L., Blakely, R.D., 1996. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol. Pharmacol. 50, 957-965.
5. Barker, E.L., Kimmel, H.L., Blakely, R.D., 1994. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol. Pharmacol. 46, 799-807.
6. Blakely, R.D., Berson, H.E., Fremeau, R.T., et al., 1991. Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66-70.
7. Bossé, R., Fumagalli, F., Jaber, M., et al., 1997. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19, 127-138.
8. Brownstein, M.J., Hoffman, B.J., 1994. Neurotransmitter transporters. Recent Prog. Horm. Res. 49, 27-42.
9. Brüss, M., Hammermann, R., Brimijoin, S., Bönisch, H., 1995. Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J. Biol. Chem. 270, 9197-9201.
10. Buck, K., Amara, S., 1994. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. U.S.A. 91, 12584-12588.
11. Buck, K.J., Amara, S.G., 1995. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48, 1030-1037.
12. + Permeation and pH regulation at a mammalian serotonin transporter. J. Neurosci. 17, 2257-2266.
13. Chen, J.-G., Liu-Chen, S., Rudnick, G., 1997. External cysteine residues in the serotonin transporter. Biochemistry 36, 1479-1486.
14. Clark, J.A., 1997. Analysis of the transmembrane topology and membrane assembly of the GAT1 γ-aminobutyric acid transporter. J. Biol. Chem. 272, 14695-14704.
15. Di Chiara, G., 1995. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38, 95-137.
16. Edwards, R.H., 1992. The transport of neurotransmitters into synaptic vesicles. Curr. Opin. Neurobiol. 2, 586-594.
17. Erickson, J., Eiden, L., 1993. Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J. Neurochem. 61, 2314-2317.
18. Erickson, J.D., Eiden, L.E., Hoffman, B.J., 1992. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. U.S.A. 89, 10993-10997.
19. Fairman, W.A., Vandenberg, R.J., Arriza, J.L., Kavanaugh, M.P., Amara, S.G., 1995. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375, 599-603.
20. Finn, J.P., III, Edwards, R.H., 1997. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 272, 16301-16307.
21. Finn, J.P., III, Edwards, R.H., 1998. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 273, 3943-3947.
22. Fischer, J.F., Cho, A.K., 1979. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208, 203-209.
23. Fon, E.A., Pothos, E.N., Sun, B.-C., Killeen, N., Sulzer, D., Edwards, R.H., 1997. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19, 1271-1283.
24. Galli, A., DeFelice, L.J., Duke, B.-J., Moore, K.R., Blakely, R.D., 1995. Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198, 2197-2212.
25. Galli, A., Petersen, C.I., deBlaquiere, M., Blakely, R.D., DeFelice, L.J., 1997. Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. J. Neurosci. 15, 3401-3411.
26. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M., Caron, M.G., 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
27. Giros, B., Mestikawy, S.E., Bertrand, L., Caron, M.G., 1991. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154.
28. Giros, B., Wang, Y.-M., Suter, S., McLeskey, S.B., Pifl, C., Caron, M.G., 1994. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985-15988.
29. Guastella, J., Nelson, N., Nelson, H., et al., 1990. Cloning and expression of a rat brain GABA transporter. Science 249, 1303-1306.
30. Haugh-Scheidt, L., Malchow, R.P., Ripps, H., 1995. GABA transport and calcium dynamics in horizontal cells from the skate retina. J. Physiol. 488, 565-576.
31. Hersch, S.M., Yi, H., Heilman, C.J., Edwards, R.H., Levey, A.I., 1997. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J. Comp. Neurol. 388, 211-227.
32. Hoffman, B.J., Mezey, E., Brownstein, M.J., 1991. Cloning of a serotonin transporter affected by antidepressants. Science 254, 579-580.
33. Jones, S.R., Gainetdinov, R.R., Wightman, R.M., Caron, M.G., 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986.
34. Kilty, J.E., Lorang, D., Amara, S.G., 1991. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579.
35. Kitayama, S., Shimada, S., Xu, H., Markham, L., Donovan, D.M., Uhl, G.R., 1992. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. U.S.A. 89, 7782-7785.
36. + transport. Synapse 15, 58-62.
37. Kozikowski, A.P., Saiah, M.K.E., Bergmann, J.S., Johnson, K.M., 1994. Structure-activity relationship studies of N-sulfonyl analogs of cocaine: role of ionic interaction in cocaine binding. J. Med. Chem. 37, 3440-3442.
38. Lester, H.A., Mager, S., Quick, M.W., Corey, J.L., 1994. Permeation properties of neurotransmitter transporters. Ann. Rev. Pharmacol. Toxicol. 34, 219-249.
39. Lin, F., Lester, H.A., Mager, S., 1996. Single-channel currents produced by the serotonin transporter and analysis of a mutation affecting ion permeation. Biophys. J. 71, 3126-3135.
40. Liu, Q.-R., Lopez-Corcuera, B., Mandiyan, S., Nelson, H., Nelson, N., 1993. Molecular characterization of four pharmacologically distinct γ-amminobutyric acid transporters in mouse brain. J. Biol. Chem. 268, 2106-2112.
41. + toxicity encodes a vesicular amine transporter. Cell 70, 539-551.
42. Liu, Y., Roghani, A., Edwards, R.H., 1992b. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. U.S.A. 89, 9074-9078.
43. Liu, Y., Edwards, R.H., 1997. The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu. Rev. Neurosci. 20, 125-156.
44. Lu, C.C., Kabakov, A., Markin, V.S., Mager, S., Frazier, G.A., Hilgemann, D.W., 1995. Membrane transport mechanisms probed by capacitance measurements with megahertz voltage clamp. Proc. Natl. Acad. Sci. U.S.A. 92, 11220-11224.
45. Mager, S., Kleinberger-Doron, N., Keshet, G.I., Davidson, N., Kanner, B.I., Lester, H.A., 1996. Ion binding and permeation at the GABA transporter GAT1. J. Neurosci. 16, 5405-5414.
46. Mager, S., Min, C., Henry, D., et al., 1994. Conducting states of a mammalian serotonin transporter. Neuron 12, 845-859.
47. Mager, S., Naeve, J., Quick, M., Labarca, C., Davidson, N., Lester, H.A., 1993. Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytes. Neuron 10, 177-188.
48. McIntire, S.L., Reimer, R.J., Schuske, K., Edwards, R.H., Jorgensen, E.M., 1997. Identification and characterization of the vesicular GABA transporter. Nature 389, 870-876.
49. Melikian, H.E., Ramamoorthy, S., Tate, C.G., Blakely, R.D., 1996. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol. Pharmacol. 50, 266-276.
50. Meltzer, P.C., Liang, A.Y., Blundell, P., et al., 1997. 2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters. J. Med. Chem. 40, 2661-2673.
51. Merickel, A., Kaback, H.R., Edwards, R.H., 1997. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition. J. Biol. Chem. 272, 5403-5408.
52. Nguyen, T.T., Amara, S.G., 1996. N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J. Neurochem. 67, 645-655.
53. Pacholczyk, T., Blakely, R.D., Amara, S.G., 1991. Expression of cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-353.
54. Peter, D., Jimenez, J., Liu, Y., Kim, J., Edwards, R.H., 1994. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269, 7231-7237.
55. Peter, D., Vu, T., Edwards, R.H., 1996. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. J. Biol. Chem. 271, 2979-2986.
56. Qian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L.J., Blakely, R.D., 1997. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17, 45-57.
57. Ritz, M.C., Lamb, R.J., Goldberg, S.R., Kuhar, M.J., 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
58. Roghani, A., Feldman, J., Kohan, S.A., et al., 1994. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. U.S.A. 91, 10620-10624.
59. Rothman, R.B., Glowa, J.R., 1995. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. Mol. Neurobiol. 11, 1-19.
60. Rudnick, G., Clark, J., 1993. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta 1144, 249-263.
61. Schuldiner, S., 1994. A molecular glimpse of vesicular monoamine transporters. J. Neurochem. 62, 2067-2078.
62. Schuldiner, S., Steiner-Mordoch, S., Yelin, R., Wall, S.C., Rudnick, G., 1993. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmacol. 44, 1227-1231.
63. Shimada, S., Kitayama, S., Lin, C.-L., et al., 1991. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
64. Sonders, M.S., Amara, S.G., 1996. Channels in transporters. Curr. Opin. Neurobiol. 6, 294-302.
65. Sonders, M.S., Zhu, S.-J., Zahniser, N.R., Kavanaugh, M.P., Amara, S.G., 1997. Multiple ionic conductances of human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974.
66. Sulzer, D., Maidment, N.T., Rayport, S., 1993. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527-535.
67. Sulzer, D., Rayport, S., 1990. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797-808.
68. Sur, C., Schloss, P., Betz, H., 1997. The rat serotonin transporter: identification of cysteine residues important for substrate transport. Biochem. Biophys. Res. Commun. 241, 68-72.
69. Takahashi, N., Miner, L.L., Sora, I., et al., 1997. VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc. Natl. Acad. Sci. U.S.A. 94, 9938-9943.
70. Usdin, T.B., Mezey, E., Chen, C., Brownstein, M.J., Hoffman, B.J., 1991. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 88, 11168-11171.
71. Varoqui, H., Diebler, M.F., Meunier, F.M., et al., 1994. Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. FEBS Lett. 342, 97-102.
72. Vaughan, R.A., Kuhar, M.J., 1996. Dopamine transporter ligand binding domains. J. Biol. Chem. 271, 21672-21680.
73. 3 pituitary cells acting via a high-affinity glutamate transporter. FASEB J. 9, 815-819.
74. Wang, J.B., Moriwaki, A., Uhl, G.R., 1995. Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression. J. Neurochem. 64, 1416-1419.
75. Wang, Y.-M., Gainetdinov, R.R., Bock, C.B., Miller, G.W., Wightman, R.M., Caron, M.G., 1997. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19, 1285-1296.
76. Wise, R.A., 1996. Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-251.